Growth Metrics

Boston Scientific (BSX) Gross Profit (2016 - 2026)

Boston Scientific's Gross Profit history spans 18 years, with the latest figure at $3.6 billion for Q1 2026.

  • On a quarterly basis, Gross Profit rose 12.59% to $3.6 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $14.3 billion, a 18.31% increase, with the full-year FY2025 number at $13.9 billion, up 20.57% from a year prior.
  • Gross Profit hit $3.6 billion in Q1 2026 for Boston Scientific, down from $3.7 billion in the prior quarter.
  • Over the last five years, Gross Profit for BSX hit a ceiling of $3.7 billion in Q4 2025 and a floor of $2.1 billion in Q1 2022.
  • Historically, Gross Profit has averaged $2.8 billion across 5 years, with a median of $2.6 billion in 2024.
  • Biggest five-year swings in Gross Profit: increased 3.57% in 2022 and later grew 22.26% in 2025.
  • Tracing BSX's Gross Profit over 5 years: stood at $2.2 billion in 2022, then increased by 15.55% to $2.6 billion in 2023, then increased by 20.01% to $3.1 billion in 2024, then rose by 18.87% to $3.7 billion in 2025, then fell by 1.77% to $3.6 billion in 2026.
  • Business Quant data shows Gross Profit for BSX at $3.6 billion in Q1 2026, $3.7 billion in Q4 2025, and $3.5 billion in Q3 2025.